Why LGBTQ+ Representation Matters to Me: Celebrating Diversity and Inclusion in Health Care In honor of LGBTQ+ Pride Month, hear firsthand from members of our chronic illness community about the vital importance of representation for the LGBTQ+ community in achieving…
Learn more about the FDA approval of new drug, Zepbound (tripeptide), for the treatment of adults with obesity.
Learn more about the approval of a new drug, Omvah ((mirikizumab-mrkz), for people with moderately to severely active ulcerative colitis.
Learn more about the approval of a new drug, BIMZELX (bimekizumab-bkzx), for people with moderate to severe plaque psoriasis.
New research has revealed encouraging findings about the effectiveness of apremilast (Otezla) in treating genital psoriasis, a condition that often carries a significant stigma.
Discover patient insights on how stylists can offer empathetic and accommodating care during salon visits for those with chronic illnesses.
This International Women’s Day, patient advocates from around the world share their advice, challenges, and how they’ve found support.
Learn more about the approval of a new drug, deucravacitinib (Sotyktu), for people with moderate to severe plaque psoriasis.
“I advocate for laws like this because we should be doing everything we can to make it easier for patients to access the medications that work for them, and copay assistance and this legislation do just that,” says Corey.
In the Global Healthy Living Foundation’s latest poll, majority agree that jokes about chronic illness are not funny, and people should use the recent Oscars as a learning.